Product Name | MF | CAS | Details |
---|
CEF32, Epstein-Barr Virus latent NA-3C (281-290) | C59H88N14O18 | Details |
CEF28, Epstein-Barr Virus latent NA-3A (603-611) | C45H83N17O13 | Details |
HBV Core (107-115) | Details |
CEF15, Epstein-Barr Virus Lytic Cycle Protein BZLF-1(190-197) | C47H82N14O10 | Details |
CEF21, Cytomegalovirus, CMV pp65 (417-426) | C38H67N13O13S | Details |
Flagelin 22 | C93H162N32O34 | 304642-91-9 | Details |
Influenza HA (126-138) | C52H81N19O22 | 207349-63-1 | Details |
Competence-Stimulating Peptide-2 | C101H172N28O23S | 1174553-84-4 | Details |
NA | Details |
4A/4B, 5A/5B Peptide | C49H73N11O22S3 | Details |
Scyliorhinin I | C59H87N13O13S | 103425-21-4 | Details |
Steroid Receptor Co-Factor Peptide | C79H136N26O21 | Details |
Indolicidin | C100H132N26O13 | 140896-21-5 | Details |
CEF17, Epstein-Barr Virus latent NA-3A (158-166) | C52H86N16O13 | Details |
VIP (1-12) | C61H88N18O22 | 120928-03-2 | Details |
TIF2 (740-753) | Details |
CD36 Peptide P(93-110) | C96H151N29O33S | Details |
HCV, NS4A-Like Peptide | Details |
CEF12, Epstein-Barr Virus latent NA3B (399-408), AVF | C49H81N15O16 | Details |
CEF14, EBV Rta Protein (28-37) | C55H81N13O18S | 216862-58-7 | Details |
Protease-Activated Receptor-1, PAR-1 Agonist, amide | Details |
Val20]-HPV 16 E7 (11-19) | Details |
TfR-T12 | C71H99N19O15S | 344618-30-0 | Details |
Transcriptional Intermediary Factor 2, Tif-2 (685-697) | Details |
CEF18, Epstein-Barr Virus latent NA-3C (258-266) | C54H91N15O15 | Details |
TRAP-6 (2-6) | C31H51N9O7 | 141136-84-7 | Details |
CEF26, Influenza Virus NP (265-274) | C43H77N15O11 | Details |
PrP (89-106) | C91H135N27O28 | Details |
CEF6 | C48H78N10O14S | 913545-15-0 | Details |
CEF10, Epstein-Barr Virus LMP2 (426-434) | C39H71N9O11S2 | Details |
Influenza HA (110-120) | C68H97N15O19 | Details |
HPV E7 protein (49-57) | Details |
TET 830 modified/T-helper epitope from tetanus toxoid | C83H134N20O24 | Details |
CSP1 | Details |
Influenza HA (307-319) | C69H118N18O19 | 528526-85-4 | Details |
CEF7, Influenza Virus NP (380-388) | C55H84N16O14 | 147100-46-7 | Details |
Influenza HA (204-212) | C49H73N11O15 | Details |
Steroid Receptor Coactivator-1, SRC-1 (686-700) | Details |
Adhesion factor A | Details |
HSV-1-amide UL 26 Open Reading Frame (242-255) | C80H117N21O20S | 396716-24-8 | Details |
Influenza A NP (366-374) Strain A/NT/60/68 | C36H59N11O17S2 | Details |
Apidaecin IB | C95H150N32O23 | 123276-94-8 | Details |
CEF5, Influenza Virus NP (91-99) | C46H78N14O12 | Details |
Influenza A NP(366-374) Strain A/PR/8/35 | C38H63N11O18S2 | 132326-73-9 | Details |
Thrombin Receptor Peptide Ligand, Thrombin Receptor Antagonist | Details |
Human Platelet Factor IV 18, C18G | Details |
Human CMV pp65 (495-503) | C42H74N10O12S | 153045-21-7 | Details |
Biotinyl-KR-12 (human) | C81H140N26O18S | 2022956-47-2 | Details |
CMV pp65 peptide | Details |
KATACALCIN | C97H154N34O36S2 | 85916-47-8 | Details |
HSV-gB2 (498-505) | C41H67N11O13 | 149997-91-1 | Details |
CEF11, Epstein-Barr Virus BMLF1 (280-288) | C40H73N9O11S2 | Details |
Tau-Protein (323-335) | Details |
CEF3 | C42H74N10O12 | 199727-62-3 | Details |
Influenza HA (110-119) | C63H90N14O16 | 132031-50-6 | Details |
Glycoprotein (276-286) | C46H70N12O17S | 160543-97-5 | Details |
T-NLS peptide | C66H111N19O18S | 105425-98-7 | Details |
Bactenecin 2A | Details |
PrP (57-64) | C35H46N12O10 | Details |
CHRG01 | Details |
Soymetide-4, MITL | Details |
HIV p17 Gag (77-85) | C44H72N10O15 | 147468-65-3 | Details |
CEF9, Influenza Virus M1 128-135 | C37H60N8O11S2 | Details |
CEF1, Influenza Matrix Protein M1 (58-66) | C49H75N9O11 | 141368-69-6 | Details |
CEF29, Epstein-Barr Virus latent NA-3B (416-424) | C48H80N10O14 | Details |
GP(33-41) | C46H69N11O13S | 161928-86-5 | Details |
α-CGRP (19-37), human | C86H137N25O25 | 101233-12-9 | Details |
CEF24, Influenza Virus PB1 Peptide (591-599) | C40H60N10O15 | Details |
Histatin-8 [Hemagglutination-Inhibiting Peptide (HIP) | C70H99N25O17 | 127637-03-0 | Details |
Ac-MDKVLNRE | Details |
CEF23, Cytomegalovirus, CMV pp65 (123-131) | C50H74N14O13 | Details |
Influenza HA (518-526) | C42H69N9O15 | 186302-15-8 | Details |
CFP10 (71-85) | C72H120N24O25 | 646997-09-3 | Details |
Tau-Protein (1-16) | Details |
CEF16, Epstein-Barr Virus latent NA-3A (337-347) | C49H77N15O11 | Details |
PrP (106-114) | C41H72N14O12S2 | Details |
Chemerin-9 (149-157) | C54H66N10O13 | 676367-27-4 | Details |
CEF4 | C53H93N15O13 | 199727-68-9 | Details |
SmMLCKp, Smooth-Muscle Myosin Light-Chain Kinase (796-815), Calmodulin Binding | Details |
Substance P (8-11) | Details |
CD36 Peptide P(139-155) | C87H133N25O26S | Details |
AMPs WR | Details |
PLP (190-209) | Details |
CEF30, Epstein-Barr Virus BRLF1 (134-142) | C42H70N10O13S | Details |
Aurein 1.1 | Details |
SynB1 | C89H151N37O27 | Details |
Protease-Activated Receptor-1, PAR-1 Agonist | Details |
B8R (20-27) | Details |
PLP (56-70) | Details |
Calcitonin C-terminal Adjacent Peptide, rat | C82H117N23O27S | Details |
PrP (127-147) | C103H152N26O33S2 | Details |
CEF27, Epstein-Barr Virus BRLF-1 lytic (148-156) | C51H82N16O14 | 254110-79-7 | Details |
CEF19, Epstein-Barr Virus latent NA-3A (458-466) | C49H70N14O14S | 157876-41-0 | Details |
CEF31, Epstein-Barr Virus latent NA-3A (379-387) | C55H94N18O10 | Details |
CEF33, Cytomegalovirus, HCMV pp65 | C64H78N12O19 | Details |
Drosocin | C98H160N34O24 | 149924-99-2 | Details |
CEF25, Influenza Virus NP (44-52) | C46H74N10O17S | Details |
CEF2, Influenza Virus PA (46-54) | C60H75N11O14S | Details |
CEF22, Cytomegalovirus, CMV pp65 (378-389) | C58H90N12O24 | Details |
H-LYS-ARG-THR-GLY-GLN-TYR-LYS-LEU-OH | C44H76N14O12 | 152051-61-1 | Details |
Product Total: Product Page: | ||||
196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 |